Drug-related problem classification systems

被引:194
作者
van Mil, JWF
Westerlund, LOT
Hersberger, KE
Schaefer, MA
机构
[1] van Mil Consultancy, Zuidlaren, Netherlands
[2] Qual Inst Pharmaceut Care, Kampen, Netherlands
[3] Apoteket AB, Helsingborg, Sweden
[4] Apoteket AB, Stockholm, Sweden
[5] Univ Gothenburg, Dept Social Med, Gothenburg, Sweden
[6] Univ Basel, Inst Klin Pharm, Basel, Switzerland
[7] Humboldt Univ, Inst KlinPharmakol, Berlin, Germany
关键词
classifications; drug-related problems; drug-therapy problems; medication errors; medicine-related problems; pharmaceutical care; pharmacotherapy;
D O I
10.1345/aph.1D182
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To provide an overview of and critically appraise classifications of drug-related problems (DRPs) for use during the pharmaceutical care process and research in pharmacy. DATA SOURCES: A literature search was conducted using MEDLINE and Yahoo (January 2003) and manually. The search terms included DRP, drug-related problem, drug-therapy problem, and medicine-related problem. STUDY SELECTION AND DATA EXTRACTION: English- and German-language articles on pharmaceutical care and DRPs were reviewed. DATA SYNTHESIS: Most classifications of DRPs were identified through searching publications on pharmaceutical care and DRPs. Fourteen classifications with different focuses were found. Some classifications were hierarchical, categorized into main groups and subgroups. Various terminologies and definitions for DRPs were revealed, as well as guidelines for an optimal DRP classification. Classifications were assessed according to a clear definition, published validation method, and results reflecting process and outcomes, usability in pharmaceutical care practice, and a hierarchical structure with main groups and subgroups. CONCLUSIONS: Finding DRP classifications by computerized search of the biomedical literature with the help of PubMed proved to be difficult. No classification could be found that met all of our criteria for an optimal system. Few classifications have been validated. Three have been tested as to their usability in practice and internal consistency. The Pharmaceutical Care Network Europe system Version 4 comes closest to the defined requirements.
引用
收藏
页码:859 / 867
页数:9
相关论文
共 35 条
[1]  
Anderson AC, 2003, J Soc Admin Pharm, V20, P82
[2]  
Cipolle RJ, 1998, PHARM CARE PRACTICE, P78
[3]  
Consensus Panel, 1999, Pharm Care Espana, V1, P107
[4]  
Currie Jay D, 2003, J Am Pharm Assoc (Wash), V43, P41, DOI 10.1331/10865800360467033
[5]  
Deffenbaugh J., 1996, BEST PRACTICES HLTH, P109
[6]  
Espejo J, 2002, PHARM CARE ESP, V4, P122
[7]   Drug-related visits to the emergency department: How big is the problem? [J].
Fatel, P ;
Zed, PJ .
PHARMACOTHERAPY, 2002, 22 (07) :915-923
[8]  
*GRUP INV AT FARM, 2002, 2 GRAN CONS DRUG REL, V43, P175
[9]  
HANDL W, 2001, ED MAT
[10]   A METHOD FOR ASSESSING DRUG-THERAPY APPROPRIATENESS [J].
HANLON, JT ;
SCHMADER, KE ;
SAMSA, GP ;
WEINBERGER, M ;
UTTECH, KM ;
LEWIS, IK ;
COHEN, HJ ;
FEUSSNER, JR .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (10) :1045-1051